Maraganore wins best biopharma CEO vote; Vounatsos tops worst list
STAT readers have once again crowned the best and worst biopharma CEOs of the year — and it’s an all-Cambridge, Mass., pairing.
Related Articles
International consortium uncovers protein changes linked to neurodegenerative disease
And more health news stories of the day.
Protein structure competition, of AlphaFold fame, nearing deal to replace lost NIH funding
CASP, a popular research competition that spawned three Nobel laureates, is set to lose NIH funding.
Medicare proposes ‘efficiency’ pay cuts that would hit highly paid specialists the most
Medicare is proposing cuts to how much it pays doctors for many medical procedures, scans, and tests.
Pharmalittle: We’re reading about Trump and pharma tariffs, an abortion pill ruling, and more
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a “low tariff”
Medical school prerequisites should include microbiology
Medical schools must make microbiology a prerequisite — to prepare students not just for school but for practicing medicine.
Oncologists need to see antimicrobial resistance as a cancer care delivery crisis
Oncologists must join the global fight against microbial resistance.
Medicare proposes ‘efficiency’ pay cuts that would hit highly paid specialists the most
Medicare is proposing cuts to how much it pays doctors for many medical procedures, scans, and tests.
ViiV expands licensing deal for its HIV drug in low-income countries
ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, reflecting ongoing pressure to respond to criticism.
Women’s Health, Unstuck
Join Bill Gates and a range of experts for a discussion on flattening barriers to improving women’s health — from research labs to clini…